Our results provide new insights into the role of the NLRP3 inflammasome in pathophysiology and suggest that NLRP3 is a potential therapeutic target to inhibit macrophage activation and prevent IBD. The gene discussed is NLRP3; the disease is inflammatory bowel disease.